Obstructive Hypertrophic Cardiomyopathy (oHCM): Clinical Trials

1 trial for Obstructive Hypertrophic Cardiomyopathy (oHCM), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Obstructive Hypertrophic Cardiomyopathy (oHCM): new trials by email Literature Review of Obstructive Hypertrophic Cardiomyopathy (oHCM) trials Research Report on Obstructive Hypertrophic Cardiomyopathy (oHCM)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Mavacamten - Obstructive Hypertrophic Cardiomyopathy (oHCM)
Phase 4Not yet recruitingSecond Affiliated Hospital of Nanchang University1152026-09-012026-09-08

Narrower conditions

Cardiomyopathy, Hypertrophic (1)

Broader conditions

Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)

Interventions

MYK-461 (1)

Sponsors

Second Affiliated Hospital of Nanchang University (1)